Cited by 319Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementGlycogen Storage Diseases and Myoclonus

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase

Open access

Hunter, Roger W., Hughey, Curtis C., Lantier, Louise, Sundelin, Elias I., Peggie, Mark, Zeqiraj, Elton, Sicheri, Frank, Jessen, Niels, Wasserman, David H., Sakamoto, Kei·2018·Nature Medicine

DOI 10.1038/s41591-018-0159-7PMC PMC6207338

Open this paper in CoChat — free account Open PDF

Abstract

Metformin is a first-line drug for the treatment of individuals with type 2 diabetes, yet its precise mechanism of action remains unclear. Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP). This suppression is thought to be mediated through inhibition of mitochondrial respiratory complex I, and thus elevation of 5′-adenosine monophosphate (AMP) levels and the activation of AMP-activated protein kinase (AMPK), though this proposition has been challenged given results in mice lacking hepatic AMPK. Here we report that the AMP-inhibited enzyme fructose-1,6-bisphosphatase-1 (FBP1), a rate-controlling enzyme in gluconeogenesis, functions as a major contributor to the therapeutic action of metformin. We identified a point mutation in FBP1 that renders it insensitive to AMP while sparing regulation by fructose-2,6-bisphosphate (F-2,6-P2), and knock-in (KI) of this mutant in mice significantly reduces their response to metformin treatment. We observe this during a metformin tolerance test and in a metformin-euglycemic clamp that we have developed. The antihyperglycemic effect of metformin in high-fat diet–fed diabetic FBP1-KI mice was also significantly blunted compared to wild-type controls. Collectively, we show a new mechanism of action for metformin and provide further evidence that molecular targeting of FBP1 can have antihyperglycemic effects. The antidiabetic action of metformin raises heptocyte intracellular AMP levels, causing allosteric inhibition of fructose-1,6-bisphosphatase and thus reductions in gluconeogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0159-7

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Methods of Enzymatic Analysis
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Anorexigenic and Orexigenic Hormone Modulation of Mammalian Target of Rapamycin Complex 1 Activity and the Regulation of Hypothalamic Agouti-Related Protein mRNA Expression
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
[1] Citrate synthase
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose
Thomas, J. A., Schlender, K. K., & Larner, J. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90127-9 · Cited by 1,198
Metformin Inhibits Hepatic Gluconeogenesis in Mice Independently of the LKB1/AMPK Pathway via a Decrease in Hepatic Energy State
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Self-citation
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Cool, B. L., Zinker, B. A., Chiou, W. J. H., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A. L., Gagné, G. D., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 939
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 845
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J. (2014) · Biochemical Journal · doi:10.1042/bj20140620 · Cited by 661
A Kinetic Study of Pyrophosphate: Fructose‐6‐Phosphate Phosphotransferase from Potato Tubers
SCHAFTINGEN, E. V., Lederer, B., Bartrons, R., & Hers, H. G. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb07039.x · Cited by 652
Drug excretion mediated by a new prototype of polyspecific transporter
Gründemann, D., Gorboulev, V., Gambaryan, S. P., Veyhl, M., & Koepsell, H. (1994) · Nature · doi:10.1038/372549a0 · Cited by 642
Enzymatic analysis; a practical guide
(1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90404-l · Cited by 522
Contributions of gluconeogenesis to glucose production in the fasted state
Landau, B. R., Wahren, J., Chandramouli, V, Schumann, W. C., Ekberg, K., & Kalhan, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118803 · Cited by 487
Molecular mechanism of action of metformin: old or new insights?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Diabetologia · doi:10.1007/s00125-013-2991-0 · Cited by 479
Self-citation
Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements
Antoniewicz, M. R., Kelleher, J. K., & Stephanopoulos, G. N. (2006) · Metabolic Engineering · doi:10.1016/j.ymben.2006.01.004 · Cited by 451
Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver
Satapati, S., Sunny, N. E., Kucejova, B., Fu, X., He, T. T., Méndez-Lucas, A., Shelton, J. M., Perales, J. C., Browning, J. D., & Burgess, S. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m023382 · Cited by 407
Metformin Activates a Duodenal Ampk-Dependent Pathway to Lower Hepatic Glucose Production in Rats
Duca, F. A., Côté, C. D., Rasmussen, B. A., Zadeh-Tahmasebi, M., Rutter, G. A., Filippi, B. M., & Lam, T. K. T. (2015) · Nature Medicine · doi:10.1038/nm.3787 · Cited by 402
Radioactive method for the assay of glycogen phosphorylases
Gilboe, D. P., Larson, K., & Nuttall, F. Q. (1972) · Analytical Biochemistry · doi:10.1016/0003-2697(72)90274-6 · Cited by 399
INCA: a computational platform for isotopically non-stationary metabolic flux analysis
Young, J. D. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu015 · Cited by 393
The Stimulation of Liver Phosphorylase b by AMP, Fluoride and Sulfate
Stalmans, W., & Hers, H. G. (1975) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1975.tb04144.x · Cited by 308
Enzymatic Analysis
Passonneau, J. V., & Lowry, O. H. (1993) · Humana Press eBooks · doi:10.1007/978-1-60327-407-4 · Cited by 300
Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Tao, H., Zhang, Y., Zeng, X., Shulman, G. I., & Jin, S. (2014) · Nature Medicine · doi:10.1038/nm.3699 · Cited by 288
Metformin and the Intestine
Bailey, C. J., Wilcock, C., & Scarpello, J. H. B. (2008) · Diabetologia · doi:10.1007/s00125-008-1053-5 · Cited by 275
Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition
Bleasby, K., Castle, J. C., Roberts, C. J., Cheng, C., Bailey, W. J., Sina, J. F., Kulkarni, A., Hafey, M., Evers, R., Johnson, J. M., et al. (2006) · Xenobiotica · doi:10.1080/00498250600861751 · Cited by 269
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
Christensen, M. M. H., Brasch‐Andersen, C., Gréen, H., Nielsen, F., Damkier, P., Beck‐Nielsen, H., & Brøsen, K. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834c0010 · Cited by 259
The specificities of small molecule inhibitors of the TGFß and BMP pathways
Vogt, J., Traynor, R., & Sapkota, G. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.019 · Cited by 256
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Ouyang, J., Parakhia, R. A., & Ochs, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121806 · Cited by 251
OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
Chen, L., Shu, Y., Liang, X., Chen, E. C., Yee, S. W., Zur, A. A., Li, S., Xu, L., Keshari, K. R., Lin, M. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314939111 · Cited by 238
Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat Hepatocytes
Vincent, M., Marangos, P. J., Gruber, H. E., & Berghe, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1259 · Cited by 218
Assay of inorganic phosphate in the mild pH range, suitable for measurement of glycogen phosphorylase activity
Saheki, S., Takeda, A., & Shimazu, T. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90229-5 · Cited by 217
The problem of tissue sampling from experimental animals with respect to freezing technique, anoxia, stress and narcosis
Rp, F., Seitz, H. J., Tarnowski, W., Thiemann, V., & Weiß, C. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90170-1 · Cited by 208
An Improved Purification, Crystallization, and Some Properties of Rabbit Muscle 5'-Adenylic Acid Deaminase
Smiley, K. L., Berry, A. J., & Suelter, C. H. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95990-9 · Cited by 201
Factors underlying significant underestimations of glucokinase activity in crude liver extracts: Physiological implications of higher cellular activity
Davidson, A. L., & Arion, W. J. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90648-5 · Cited by 198
Allosteric Regulation of Glycogen Synthase Controls Glycogen Synthesis in Muscle
Bouskila, M., Hunter, R. W., Ibrahim, A. F. M., Delattre, L., Peggie, M., van Diepen, J. A., Voshol, P. J., Jensen, J., & Sakamoto, K. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.10.006 · Cited by 196
Self-citation
Alkaline Polyethylene Glycol-Based Method for Direct PCR from Bacteria, Eukaryotic Tissue Samples, and Whole Blood
Chomczyński, P., & Rymaszewski, M. (2006) · BioTechniques · doi:10.2144/000112149 · Cited by 195
5-Aminoimidazole-4-Carboxamide-1-β- d -Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase–Independent Effect on Glucokinase Translocation
Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N. F., Vertommen, D., Andréelli, F., Viollet, B., & Hue, L. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1178 · Cited by 183
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes
Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X., Chu, X., Still, C. D., Gerhard, G. S., & Shulman, G. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812547106 · Cited by 177
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
Patel, K., Foretz, M., Marion, A., Campbell, D. G., Gourlay, R., Boudaba, N., Tournier, E., Titchenell, P. M., Peggie, M. W., Deák, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5535 · Cited by 171
Self-citation
Hepatic pyruvate kinase. Regulation by glucagon, cyclic adenosine 3'-5'-monophosphate, and insulin in the perfused rat liver.
Blair, J. B., Cimbala, M. A., Foster, J. L., & Morgan, R. A. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33408-7 · Cited by 170
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes
Erion, M. D., van Poelje, P. D., Dang, Q., Kasibhatla, S. R., Potter, S. C., Reddy, M. R., Reddy, K. R., Jiang, T., & Lipscomb, W. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502983102 · Cited by 163
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C. M., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188 · Cited by 157
Self-citation
Improved ion-pair high-performance liquid chromatographic method for the quantification of a wide variety of nucleotides and sugar—nucleotides in animal cells
Ryll, T., & Wagner, R. (1991) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80202-n · Cited by 155
Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
In Vivo Imaging of Human 11 C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
Gormsen, L. C., Sundelin, E. I. O., Jensen, J., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Christensen, M. M. H., Brøsen, K., Frøkiær, J., & Jessen, N. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.177774 · Cited by 146
Self-citation
Inactivation of phosphofructokinase by glucagon in rat hepatocytes.
Castaño, J. G., Nieto, A., & Felíu, J. E. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50447-6 · Cited by 137
Pharmacokinetic-Pharmacodynamic Analysis of the Glucose-Lowering Effect of Metformin in Diabetic Rats Reveals First-Pass Pharmacodynamic Effect
Stepensky, D., Friedman, M., Raz, I., & Hoffman, A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.861 · Cited by 137
Measuring Deuterium Enrichment of Glucose Hydrogen Atoms by Gas Chromatography/Mass Spectrometry
Antoniewicz, M. R., Kelleher, J. K., & Stephanopoulos, G. N. (2011) · Analytical Chemistry · doi:10.1021/ac200012p · Cited by 137
Prior AICAR Stimulation Increases Insulin Sensitivity in Mouse Skeletal Muscle in an AMPK-Dependent Manner
Kjøbsted, R., Treebak, J. T., Fentz, J., Lantier, L., Viollet, B., Birk, J. B., Schjerling, P., Björnholm, M., Zierath, J. R., & Wojtaszewski, J. F. P. (2014) · Diabetes · doi:10.2337/db14-1402 · Cited by 135
Self-citation
Mechanism of Action of Compound-13: An α1-Selective Small Molecule Activator of AMPK
Hunter, R. W., Foretz, M., Bultot, L., Fullerton, M. D., Deák, M., Ross, F. A., Hawley, S. A., Shpiro, N., Viollet, B., Barron, D., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.05.014 · Cited by 132
Self-citation
Molecular Cloning, Functional Characterization and Tissue Distribution of Rat H+/Organic Cation Antiporter MATE1
Terada, T., Masuda, S., Asaka, J., Tsuda, M., Katsura, T., & Inui, K. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9016-3 · Cited by 130
Rapid determination of metformin in human plasma using ion-pair HPLC
Zarghi, A., Foroutan, S. M., Shafaati, A., & Khoddam, A. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00608-8 · Cited by 119
Hepatic fructose-1,6-diphosphatase deficiency
Pagliara, A. S., Karl, I. E., Keating, J., Brown, B. I., & KIPNIS, D. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107018 · Cited by 114
Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5′-diphosphate as nucleotide substrate
Petrescu, I., Bojan, O., Saied, M., Bârzu, O., Schmidt, F. H., & Kühnle, H. F. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90582-7 · Cited by 113
Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action
Takashima, M., Ogawa, W., Hayashi, K., Inoue, H., Kinoshita, S., Okamoto, Y., Sakaue, H., Wataoka, Y., Emi, A., Senga, Y., et al. (2010) · Diabetes · doi:10.2337/db09-1679 · Cited by 112
Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes
Dang, Q., Kasibhatla, S. R., Reddy, K. R., Jiang, T., Reddy, M. R., Potter, S. C., Fujitaki, J. M., van Poelje, P. D., Huang, J., Lipscomb, W. N., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074871l · Cited by 103
Hypoglycaemic effect of AICAriboside in mice
Vincent, M. F., Erion, M. D., Gruber, H. E., & den Berghe, G. V. (1996) · Diabetologia · doi:10.1007/bf02658500 · Cited by 93
[11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency
Jensen, J., Sundelin, E. I. O., Jakobsen, S., Gormsen, L. C., Munk, O. L., Frøkiær, J., & Jessen, N. (2016) · Diabetes · doi:10.2337/db16-0032 · Cited by 91
Self-citation
Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations
Lalau, J., Lemaire‐Hurtel, A., & Lacroix, C. (2011) · Clinical Drug Investigation · doi:10.2165/11588310-000000000-00000 · Cited by 87
The allosteric site of human liver fructose-1,6-bisphosphatase. Analysis of six AMP site mutants based on the crystal structure.
Gidh‐Jain, M., Zhang, Y., van Poelje, P. D., Liang, J. Y., Huang, S., Kim, J., Elliott, J. T., Erion, M. D., Pilkis, S. J., & El‐Maghrabi, M. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47047-0 · Cited by 82
Mass spectrometry-based microassay of2H and13C plasma glucose labeling to quantify liver metabolic fluxes in vivo
Hasenour, C. M., Wall, M. L., Ridley, D. E., Hughey, C. C., James, F. D., Wasserman, D. H., & Young, J. D. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00003.2015 · Cited by 80
Self-citation
5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) Effect on Glucose Production, but Not Energy Metabolism, Is Independent of Hepatic AMPK in Vivo
Hasenour, C. M., Ridley, D. E., Hughey, C. C., James, F. D., Donahue, E. P., Shearer, J., Viollet, B., Foretz, M., & Wasserman, D. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.528232 · Cited by 76
Self-citation
Fructose-1,6-Bisphosphatase Regulates Glucose-Stimulated Insulin Secretion of Mouse Pancreatic β-Cells
Zhang, Y., Xie, Z., Zhou, G., Zhang, H., Lu, J., & Zhang, W. J. (2010) · Endocrinology · doi:10.1210/en.2009-1185 · Cited by 36
Intravenous AICAR During Hyperinsulinemia Induces Systemic Hemodynamic Changes but Has No Local Metabolic Effect
Bosselaar, M., Smits, P., van Loon, L. J. C., & Tack, C. J. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010382912 · Cited by 30
Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats
Yoshida, T., Okuno, A., Tanaka, J., Takahashi, K., Nakashima, R., Kanda, S., Ogawa, J., Hagisawa, Y., & Fujiwara, T. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.003 · Cited by 29
Purification and Properties of Mouse Liver Fructose 1, 6-Bisphosphatase
Tashima, Y., MIZUNUMA, H., & Hasegawa, M. (1979) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132603 · Cited by 25
Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes
Vincent, M. F., Bontemps, F., & den Berghe, G. V. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00413-3 · Cited by 25
Mutations in the Hinge of a Dynamic Loop Broadly Influence Functional Properties of Fructose-1,6-bisphosphatase
Nelson, S. W., Choe, J., Honzatko, R. B., & Fromm, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000473200 · Cited by 25
A PET Tracer for Renal Organic Cation Transporters,11C-Metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies
Jakobsen, S., Busk, M., Jensen, J., Munk, O. L., Zois, N. E., Alstrup, A. K. O., Jessen, N., & Frøkiær, J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.169292 · Cited by 25
Self-citation
Discovery of fructose-1,6-bisphosphatase inhibitors for the treatment of type 2 diabetes.
van Poelje, P. D., Dang, Q., & Erion, M. D. (2007) · PubMed · Cited by 20
Shared active sites of fructose-1,6-bisphosphatase. Arginine 243 mediates substrate binding and fructose 2,6-bisphosphate inhibition.
Giroux, E. L., Williams, M., & Kantrowitz, E. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31708-3 · Cited by 17
A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate
McCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0597 · Cited by 16
d-Fructose-1,6-diphosphate
Racker, E. (1965) · Elsevier eBooks · doi:10.1016/b978-0-12-395630-9.50031-1 · Cited by 12
Enzymatic assay of hemoglobin in tissue homogenates with chlorpromazine
Nakamura, K., Maeda, H., & Kawaguchi, H. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90196-5 · Cited by 8
Adenosine 5′-monophosphate-removing system in fructose-1,6-bisphosphatase assay mixture: A new approach
Han, P. F., Han, G., McBay, H. C., & Johnson, J. D. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90280-9 · Cited by 6

Research works printed but not linked: 1

Noll, F. Methods of Enzymatic Analysis 3rd edn, Vol. 6 (ed. Bergmeyer, H. U.) 582–588 (Verlag Chemie, Weinheim, Germany, 1984).

Sorted by citations

New insights into activation and function of the AMPK
Steinberg, G. R., & Hardie, D. G. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00547-x · Cited by 1,074
Cellular and Molecular Mechanisms of Metformin Action
LaMoia, T. E., & Shulman, G. I. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa023 · Cited by 791
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Metformin: update on mechanisms of action and repurposing potential
Foretz, M., Guigas, B., & Viollet, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00833-4 · Cited by 791
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686

See all 319

Authors: Hunter, R. W., Hughey, C. C., Lantier, L., Sundelin, E. I., Peggie, M., Zeqiraj, E., Sicheri, F., Jessen, N., Wasserman, D. H., & Sakamoto, K.
Affiliations: University of Bristol (GB)
Vanderbilt University (US)
Aarhus University (DK)
University of Dundee (GB)
Mount Sinai Hospital (CA)
Corresponding author: Sakamoto, Kei
ORCID: Hunter, Roger W.
Hughey, Curtis C.
Lantier, Louise
Sundelin, Elias I.
Peggie, Mark
Zeqiraj, Elton
Sicheri, Frank
Jessen, Niels
Wasserman, David H.
Sakamoto, Kei
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2018-08-27
Volume: 24
Issue: 9
Pages: 1395-1406
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/s41591-018-0159-7
PMC: PMC6207338
OpenAlex: W2888330909
Cited by: 313
References: 86
Citations by year: 2026: 25 · 2025: 33 · 2024: 47 · 2023: 53 · 2022: 49 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 4
FWCI: 9.51
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature Medicine (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
Explore Bristol Research (publishedVersion, other-oa)
White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Bristol Research (University of Bristol) (submittedVersion, other-oa)
Funders: Vanderbilt University (DK059637)
Wellcome Trust (092381)
Novo Nordisk
Danmarks Frie Forskningsfond (4183-00384)
Novo Nordisk Fonden (NNF13OC0003882, NNF17SA0031230-1)
Canadian Institutes of Health Research (143277)
National Institute of Diabetes and Digestive and Kidney Diseases (U2CDK059637, U24DK059637, R37DK050277, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Keywords: metformin, FBP1, hepatic glucose production, gluconeogenesis, AMPK, fructose-2,6-bisphosphate, type 2 diabetes, high-fat diet, euglycemic clamp
MeSH terms: Adenosine Monophosphate, Aminoimidazole Carboxamide, Animals, Base Sequence, Chickens, Disease Models, Animal, Glucose, Fructose-Bisphosphatase, Homeostasis, Humans, Hypoglycemia, Liver, Metformin, Mice, Inbred C57BL, Mutation, Obesity, Prodrugs, Ribonucleotides, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks